Impacto de um programa de reabilita??o na gest?o urin?ria do doente acometido por acidente vascular cerebral

Objetivo: avaliar o efeito de um programa de Enfermagem de Reabilita??o na gest?o da incontin?ncia urin?ria na mulher ap?s acidente vascular cerebral. M?todo: estudo quantitativo, qu?si-experimental, longitudinal, realizado numa unidade de convalescen?a do distrito de Viana do Castelo, Portugal, entre o per?odo de Setembro de 2018 a Mar?o de 2019. A amostra, constitu?da por mulheres (n=30) entre os 45 e 90 anos, com incontin?ncia urin?ria ap?s AVC, divididas em dois grupos: grupo experimental (n=15) e grupo de controle (n=15). Apenas ao grupo experimental foi aplicado um programa de reabilita??o funcional durante 4 semanas, composto por mudan?as comportamentais e um plano de exerc?cios de refor?o dos m?sculos do pavimento p?lvico, tendo-se avaliado, antes e depois da interven??o, o impacto da incontin?ncia urin?ria na sua vida. Resultados: verificamos correla??o estaticamente significativa entre o grau de incapacidade funcional e o impacto da incontin?ncia urin?ria (r=-0,499; p=0,005), concluindo que o grau de incapacidade funcional global influencia o impacto da incontin?ncia urin?ria na qualidade de vida. O programa de reabilita??o funcional realizado no grupo experimental obteve resultados positivos ao n?vel da diminui??o da frequ?ncia urin?ria (t=6,985, p=0,000) e da quantidade de perdas de urina (Z=-2,762, p=0,006). Conclus?o: o programa de reabilita??o funcional teve um impacto positivo na diminui??o da frequ?ncia e quantidade de perdas de urinaDA10-CEBF-4D75 | Maria Salom? Martins FerreiraN/

La sierodiagnosi della toxoplasmosi nella gravida e nel neonato: esperienze dell’unità operativa dell’Azienda Sanitaria di Bolzano (Laboratorio di Microbiologia e Virologia)

Serodiagnosis of T. gondii infection is difficult because the disease can manifest in several possible ways and because of the particolar dynamic of anticorpal response.The resulting interpretation problems entail prognostic, therapeutic and ethical difficulties in the case of pregnant women and their children.The resolution of these problems goes through an extremly articulate path: the information provided by screening tests intersects with results of supplementary assays and can be enriched thanks to complementary markers (IgA) and second-level tests (IgGavidity). Each laboratory must be able to choose and to combine complementary investigation methods and to plan an adequately diagnostic strategy. Sera arriving to our laboratory undergo screening by enzyme immunoassays Axsym Toxo IgG/IgM (Abbott). Subsequently confirmation of positive, weak positive and doubtful results is entrusted to the assays VIDAS Toxo IgGII/IgM (bioMérieux), and in case of newborns to the assay ETI-TOXO-MReverse Plus (diaSorin). IgA antibodies are determined by immunoassay ETI-TOXO-A-Reverse Plus (diaSorin); the IgG-avidity is evaluated by test Toxo-IgG-avidity (bioMérieux). Analysis of toxoplasma infections occured during pregnancyas resulting by a 3 years survey period, shows that combined use of our assays contribuites to a correct diagnosis. The contribution obtained by the comparison of evaluation IgGAxsym/IgG VIDAS, provides very useful clues to evaluate the infection degree in advances with respect to evaluation of IgG-avidity

Has VZV epidemiology changed in Italy? Results of a seroprevalence study

The aim of the study was to evaluate if and how varicella prevalence has changed in Italy. In particular a seroprevalence study was performed, comparing it to similar surveys conducted in pre-immunization era. During 2013–2014, sera obtained from blood samples taken for diagnostic purposes or routine investigations were collected in collaboration with at least one laboratory/center for each region, following the approval of the Ethics Committee. Data were stratified by sex and age. All samples were processed in a national reference laboratory by an immunoassay with high sensitivity and specificity. Statutory notifications, national hospital discharge database and mortality data related to VZV infection were analyzed as well. A total of 3707 sera were collected and tested. In the studied period both incidence and hospitalization rates decreased and about 5 deaths per year have been registered. The seroprevalence decreased in the first year of life in subjects passively protected by their mother, followed by an increase in the following age classes. The overall antibody prevalence was 84%. The comparison with surveys conducted with the same methodology in 1996–1997 and 2003–2004 showed significant differences in age groups 1–19 y. The study confirms that in Italy VZV infection typically occurs in children. The impact of varicella on Italian population is changing. The comparison between studies performed in different periods shows a significant increase of seropositivity in age class 1–4 years, expression of vaccine interventions already adopted in some regions

[Sero-epidemiology of VZV infection in Italy: impact evaluation of extensive vaccination]

Eight Italian Regions have begun offering vaccination against varicella to children aged 13-15 months, with a second dose at 5-6 years of age. A serosurvey was conducted to evaluate the impact of extensive vaccination in these "pilot" Regions